The Asia Pacific boss of Canopy Growth has insisted Australia needs to address the affordability of medicinal cannabis, as he pointed to Germany as a market that has “nailed” the subsidy issue.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Ben Quirin, the Melbourne-based managing director of Canopy Growth APAC, said the lack of financial help in Australia compared to the insurance-led reimbursements for medicinal cannabis in Germany, was the “critical difference” between the frameworks of each nation.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...